BioPharmSignal logoBioPharmSignal

Biotech News

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care

Hyperfine (HYPR)HyperfineCompany update

Recent publications in the prominent Journal of Neurosurgery and Stroke provide new evidence supporting the clinical value of the Swoop system in stroke care and neurosurgical settings. GUILFORD, Conn. --(BUSINESS WIRE)--Jul. 30, 2026-- Hyperfine, Inc.

Related news

HYPRHyperfine2026-06-18 12:15 EST

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

HYPRHyperfine2026-07-01 12:15 EST

Hyperfine Announces European Launch of Next-Generation Swoop® System

IRTCiRhythm2026-08-06 20:06 EST

iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

ICCMIceCure Medical2026-06-23 12:10 EST

IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer

ADPTAdaptive Biotechnologies2026-05-29 11:30 EST

At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research

ICCMIceCure Medical2026-07-06 12:11 EST

IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer

TMCITreace Medical Concepts2026-06-18 11:05 EST

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

PAVMPAVmed2026-08-05 12:46 EST

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

DCTHDelcath Systems2026-07-09 12:00 EST

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer

AEMDAethlon Medical2026-06-26 12:01 EST

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®

View all latest news

Hyperfine

Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of...

Recent company news

HYPRHyperfine2026-08-06 20:05 EST

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

HYPRHyperfine2026-07-30 12:15 EST

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care

HYPRHyperfine2026-07-23 20:05 EST

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

HYPRHyperfine2026-07-01 12:15 EST

Hyperfine Announces European Launch of Next-Generation Swoop® System

HYPRHyperfine2026-06-22 12:15 EST

Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care

Stock data

Close
0.98 USD
Market cap
148.91M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States